January 25, 2012

The Food and Drug Administration has approved a topical treatment made by Leo Pharma for a skin condition that can lead to cancer, the drug maker said Wednesday.

January 25, 2012

Johnson & Johnson is preparing to turn the corner with its McNeil Consumer Healthcare business, J&J chairman and CEO William Weldon told analysts during the company's fourth-quarter earnings call Tuesday.

January 23, 2012

A panel of experts at the Food and Drug Administration has declined to recommend approval for a topical drug for preventing premature birth in pregnant women, the drug's manufacturers said.

January 20, 2012

Bottom Dollar Food announced grand opening dates for its first 14 stores in the greater Pittsburgh and Youngstown, Ohio, markets, with its first seven stores opening on Jan. 26. Seven additional stores will open on Feb. 9.

January 20, 2012

Drug maker Bristol-Myers Squibb has donated $6.9 million to a nonprofit group that helps people pay for medical treatments, the company said.

January 20, 2012

In the Feb. 7, 2011, issue, Drug Store News named three major issues that would define 2011 for the world of generic drugs. Those issues were drug safety, generic user fees and patent settlements.

January 19, 2012

The Food and Drug Administration has declined to approve a drug for Type 2 diabetes made by Bristol-Myers Squibb and AstraZeneca, saying it needs additional clinical data, the companies said Thursday.

January 19, 2012

Generic drug maker Watson Pharmaceuticals has launched its version of a contraceptive made by Bayer HealthCare Pharmaceuticals, Watson said.

January 18, 2012

A weight-loss products and programs provider has launched two new salad spray dressings.

January 17, 2012

Danish drug maker Novo Nordisk is partnering with cooking show host Paula Deen to launch a campaign to help adults find ways to manage challenges associated with Type 2 diabetes, the company said Tuesday.

January 16, 2012

Dove is pairing its chocolate with a new bite-sized candy that combines taste and texture.

January 16, 2012

Beauty brands rapidly are moving ahead with their social and mobile strategies to allow viral campaigns and create new consumer relations opportunities. But there’s no cookie-cutter approach, and brands are experimenting with what approaches work best for their business, according to a new report by consulting and research firm Kline.

January 12, 2012

Drug maker Octapharma USA has appointed David Holliday as VP commercial development, the company said.

January 10, 2012

Grocer A&P has announced plans to shutter 14 stores in four states as it prepares to emerge from bankruptcy.

January 9, 2012

A decade ago, Unilever revolutionized the men’s grooming segment with the launch of Axe, which has since become a leading men’s grooming brand. Now the brand is looking to make history again with the launch of its first-ever, limited-edition fragrance for her.

January 6, 2012

Sandoz has launched a shampoo used to treat severe scalp psoriasis, the generic drug maker said.

January 5, 2012

The Vitamin Shoppe on Thursday announced the launch of a sports nutrition supplement line called True Athlete.

January 4, 2012

The Food and Drug Administration has approved a generic version of a drug for attention deficit hyperactivity disorder made by Actavis, the drug maker said Wednesday.

January 4, 2012

Panasonic Healthcare Group on Tuesday announced the introduction of the R1-W digital hearing instrument, a line of hearing products that appeals to a broader user base of people with mild to severe hearing loss.

January 3, 2012

Pfizer Consumer Healthcare is giving pain a bad name in marketing its pain-relief brand Advil as the “good” medicine, with Jon Bon Jovi signing on as a company spokesman.

December 22, 2011

Drug maker Actavis is partnering with QRxPharma to sell what the former called a novel pain drug in the United States.

December 20, 2011

Generic drug maker Watson and biotech manufacturer Amgen will work together to develop biosimilar antibodies for treating cancer, the two companies said.

December 19, 2011

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

December 19, 2011

Bayer recently engaged the Goldstein Group to rejuvenate the cough-cold Neo-Synephrine brand and improve the brand's identity on shelf.